Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2008 Jan 15;98(1):15-21.
doi: 10.1038/sj.bjc.6604146. Epub 2008 Jan 8.

HPV and cervical cancer: screening or vaccination?

F X Bosch  1 , X Castellsagué, S de Sanjosé
Affiliations
Review

HPV and cervical cancer: screening or vaccination?

F X Bosch et al. Br J Cancer. .

Abstract

Following the demonstration of the superior validity of human papillomavirus (HPV) tests in screening for cervical cancer and the arrival of highly efficacious HPV 16 and 18 vaccines, cervical cancer prevention enters a time of sustainable introduction in developing countries. Multidisciplinary efforts and novel protocols are being developed, and challenging situations are being faced to make cervical cancer, still the number two cancer in women worldwide, an eradicable condition.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Expanded Program of Immunization 1980–2005 DTP3+ coverage by level of development.
Figure 2
Figure 2
World population prospects for women ⩾15 years.
Figure 3
Figure 3
Worldwide female population and a speculative anticipation on the initial introduction of HPV vaccines.
See this image and copyright information in PMC

References

    1. Almonte M, Ferreccio C, Winkler JL, Cuzick J, Tsu V, Robles S, Takashashi R, Sasieni P (2007) Cervical screening by visual inspection, HPV testing, liquid-based and conventional cytology in Amazonian Peru. Int J Cancer 121: 796–802 - PubMed
    1. Arbyn M, Sasieni P, Meijer CJ, Clavel C, Koliopoulos G, Dillner J (2006) Chapter 9: Clinical applications of HPV testing: a summary of meta-analyses. Vaccine 24(Suppl 3): S78–S89 - PubMed
    1. Castellsague X, Diaz M, de Sanjose S, Munoz N, Herrero R, Franceschi S, Peeling RW, Ashley R, Smith JS, Snijders PJ, Meijer CJ, Bosch FX (2006) Worldwide human papillomavirus etiology of cervical adenocarcinoma and its cofactors: implications for screening and prevention. J Natl Cancer Inst 98: 303–315 - PubMed
    1. Centers for Disease Control and Prevention (2007) Quadrivalent Human Papillomavirus Vaccine. Recommendations of the Advisory Committee on Immunization Practices (ACIP). http://www.cdc.gov/mmwR/preview/mmwrhtml/rr56e312a1.htm 56: 1–24 - PubMed
    1. Cuzick J, Clavel C, Petry KU, Meijer CJ, Hoyer H, Ratnam S, Szarewski A, Birembaut P, Kulasingam S, Sasieni P, Iftner T (2006a) Overview of the European and North American studies on HPV testing in primary cervical cancer screening. Int J Cancer 119: 1095–1101 - PubMed

Publication types

MeSH terms

Substances